TOWSE MATTHEW W 4
4 · NxStage Medical, Inc. · Filed Oct 23, 2017
Insider Transaction Report
Form 4
TOWSE MATTHEW W
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-10-20$27.50/sh−4,030$110,825→ 24,421 total - Exercise/Conversion
Common Stock
2017-10-20$14.05/sh+4,030$56,622→ 28,451 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-10-20−4,030→ 0 totalExercise: $14.05From: 2014-07-15Exp: 2023-07-14→ Common Stock (4,030 underlying)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.